Inhibition
Showing 26 - 50 of >10,000
And Immuno-meDIated Adverse Events in Anti-cancer
Not yet recruiting
- Cancer
- (no location specified)
Jun 26, 2023
Re-EValuating Inhibition of Stress Erosions - COVID-19 Cohort
Recruiting
- COVID-19
- GastroIntestinal Bleeding
- Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial (NCT03374800)
-
Hamilton, Ontario, CanadaSt Joseph's Healthcare Hamilton
Feb 6, 2023
Rosacea, Erythematotelangiectatic Trial in Albany (Trametinib)
Recruiting
- Rosacea, Erythematotelangiectatic
-
Albany, New YorkSamuel S. Stratton VA Medical Center
Nov 9, 2022
The Sense of Small and Inhibition in Obesity
Recruiting
- Obesity
- Experimental Task
-
Piancavallo, VCO, ItalyIRCCS Istituto Auxologico Italiano - Ospedale San Giuseppe
Mar 3, 2023
Fibrolamellar Hepatocellular Carcinoma Trial in Tuebingen (Fusion-VAC-XS15)
Not yet recruiting
- Fibrolamellar Hepatocellular Carcinoma
-
Tuebingen, Baden-Würtemberg, GermanyUniversity Hospital Tuebingen
Jun 29, 2023
Glioblastoma Trial (Dose escalation of radiation dose beyond the therapeutic standard)
Not yet recruiting
- Glioblastoma
- Dose escalation of radiation dose beyond the therapeutic standard
- (no location specified)
May 13, 2023
Knee Osteoarthritis, Arthrogenic Muscle Inhibitions Trial in Rozzano (AOT + MI, Control AOT + MI)
Recruiting
- Knee Osteoarthritis
- Arthrogenic Muscle Inhibitions
- AOT + MI
- Control AOT + MI
-
Rozzano, ItalyIstituto Clinico Humanitas
Aug 16, 2023
Dystonia Trial in Atlanta (Transcranial Magnetic Stimulation)
Recruiting
- Dystonia
- Transcranial Magnetic Stimulation
-
Atlanta, GeorgiaEmory University School of Medicine
Jan 30, 2023
Immunomodulatory Effects of PCSK9 Inhibition
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- +3 more
- Contrast-enhanced CCTA
- 99mTc-tilmanocept SPECT/CT scanning
-
Boston, MassachusettsMassachusetts General Hospital
Jan 30, 2023
Granuloma Annulare Trial in New Haven (Abrocitinib 200 mg)
Not yet recruiting
- Granuloma Annulare
- Abrocitinib 200 mg
-
New Haven, ConnecticutYale University
Dec 19, 2022
Multiple Myeloma Trial in Roma, Rome (ATAC-seq and ChIP-seq)
Recruiting
- Multiple Myeloma
- ATAC-seq and ChIP-seq
-
Roma, Italy
- +1 more
May 4, 2023
NAFLD Trial in Maastricht (Ketohexokinase inhibition, Placebo)
Recruiting
- NAFLD
- Ketohexokinase inhibition
- Placebo
-
Maastricht, Limburg, NetherlandsMaastricht University Medical centre
Jul 14, 2022
Inhibition of Autophagy Synergizes Anti-tumor Effect Trial in Guangzhou (100mg bid dose of hydroxychloroquine combined with
Recruiting
- Inhibition of Autophagy Synergizes Anti-tumor Effect
- 100mg bid dose of hydroxychloroquine combined with three predefined dose groups of palbociclib
- RP2D dose of 100mg bid of hydroxychloroquine combined with palbociclib was selected for phase II clinical trial.
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jul 19, 2023
Neck Pain and Forward Head Posture Trial (Integrated Neuromuscular inhibition, traditional treatment)
Not yet recruiting
- Neck Pain and Forward Head Posture
- Integrated Neuromuscular inhibition
- traditional treatment
- (no location specified)
Jul 6, 2022
Obese, Endothelial Function Trial in Stockholm (N?-hydroxy-nor-arginine)
Completed
- Obese
- Endothelial Function
-
Stockholm, SwedenKarolinska Institutet, Karolinska University Hospital
Sep 7, 2022
Anterior Cruciate Ligament Rupture Trial in Toulouse (functional brain MRI)
Recruiting
- Anterior Cruciate Ligament Rupture
- functional brain MRI
-
Toulouse, Occitanie, FrancePierre Paul Riquet Hospital
Jan 2, 2023
Lactation Suppressed Trial in Afula (Cabergoline, Pyridoxine)
Completed
- Lactation Suppressed
-
Afula, IsraelHaEmek Medical Center
Nov 10, 2022
Trigger Point Pain, Myofascial Trial in Rawalpindi (Integrated neuromuscular inhibition technique, Myofascial Release)
Recruiting
- Trigger Point Pain, Myofascial
- Integrated neuromuscular inhibition technique
- Myofascial Release
-
Rawalpindi, Punjab, PakistanBenazir Bhutto Hospital
Aug 17, 2022
Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases
Recruiting
- Eosinophilic Myeloid Neoplasm
- Hypereosinophilic Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Heart Failure Trial in New Haven (LCZ 696, Placebo, Para-aminohippurate)
Recruiting
- Heart Failure
- LCZ 696
- +4 more
-
New Haven, ConnecticutYale New Haven Hospital
Dec 27, 2022
Multiple Sclerosis Trial in Prague (Neuroproprioceptive "facilitation and inhibition" in virtual reality, Neuroproprioceptive
Recruiting
- Multiple Sclerosis
- Neuroproprioceptive "facilitation and inhibition" in virtual reality
- Neuroproprioceptive "facilitation and inhibition"
-
Prague, Czechia
- +1 more
Oct 10, 2022
Dyspnea, Muscle Strain Trial in Kelowna (Fentanyl, Saline)
Not yet recruiting
- Dyspnea
- Muscle Strain
- Fentanyl
- Saline
-
Kelowna, British Columbia, CanadaUniversity of British Columbia - Okanagan Campus
Nov 19, 2022
OCD, Tricholemmoma, Skin-Picking Trial (Computerized cognitive training, Computerized training)
Recruiting
- Obsessive-Compulsive Disorder
- +2 more
- Computerized cognitive training
- Computerized placebo training
-
Milwaukee, WisconsinUWM Anxiety Disorders Laboratory
Dec 29, 2022